Reliable preoperative staging of cervical cancer is important to evaluate and compare the results of different therapeutic modalities, including, surgical treatment, chemotherapy and radiation therapy. The diagnostic reliability of preoperative staging of cervical cancer by cervical biopsy and endocervical curettage was evaluated by a retrospective diagnostic study. The results of this preoperative staging were compared with the stage of cancer set on the basis of histopathological examination of the samples. Only patients who were clinically staged as early (operable) to the disease stage were included in the study. Postoperative diagnosis in 98 patients was exocervical cancer, in 12 endocervical cancer in 5 it was H-SIL (CIN III), and in 4 patients it was chronic cervicitis. The diagnostic reliability of preoperative staging of cervical cancer by cervical biopsy and endocervical curettage was 76.9%. In order to reduce errors in the staging of cervical cancer, it is advised that it be performed in specialized cancer centers by an experienced oncology gynecologist.

This study aimed to evaluate the degree of involvement and infiltration of the pelvic lymph glands in endometrial cancer. The retrospective study included patients who were diagnosed with endometrial cancer after exploratory curettage, and who were then referred for surgical treatment with partial or total pelvic lymphadenectomy. We analyzed 99 patients who met the inclusion criteria. Pelvic lymphadenectomy is the treatment of choice in patients with medium and high risk endometrial cancer for disease recurrence. Given the importance of the evaluated issue, it is necessary to perform randomized studies to examine the therapeutic effect of pelvic and paraaortic lymphadenectomy, especially in patients at medium and high risk for recurrence of endometrial cancer.